Displaying 151 - 152 of 152 results
Released Company Title Industry Topic
26 May 2021
07:00 CEST
NORDIC NANOVECTOR Nordic Nanovector ASA: Resultat for første kvartal 2021 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
25 May 2021
07:00 CEST
NORDIC NANOVECTOR Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State